邁越科技(02501.HK)盈警:預期2023年溢利同比減少不超過60%
格隆匯3月20日丨邁越科技(02501.HK)公吿,根據對集團截至2023年12月31日止年度的未經審核綜合管理賬目初步審閲,集團預期於回顧期間錄得年內溢利較截至2022年12月31日止年度的約人民幣4910萬元減少不超過60%。
董事會認為,上述年內溢利預期下降主要歸因於:相較截至2022年12月31日止年度,(i)集團於回顧期間源自綜合IT解決方案服務分部的收入及毛利減少,主要因集團於回顧期間承接的項目數量減少,以及承接的部分項目因項目要求和情況不同而導致毛利率降低;及(ii)回顧期間產生大量上市開支。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.